Hironori Hayashi

Hironori Hayashi

Auto-generated profile, based on publicly available information

Hironori Hayashi

Gastroenterologic Surgery, Kanazawa University, Kanazawa, Ishikawa, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in Anticancer Research
Verified
Journal Article
Open access
PDF file
TMTomoharu Miyashita
Tomoharu Miyashita
HTHidehiro Tajima
Hidehiro Tajima
IMIsamu Makino
Isamu Makino
MOMitsuyoshi Okazaki
Mitsuyoshi Okazaki
TYTakahisa Yamaguchi
Takahisa Yamaguchi
TOTetsuo Ohta
Tetsuo Ohta
Background: In this study, the effects of neoadjuvant chemotherapy (NAC) on cancer-associated fibroblasts (CAFs) in pancreatic cancer stroma were investigated. Materials and Methods: Density of α-smooth muscle actin (αSMA)-positive fibroblasts in resected surgical specimens from untreated patients, patients receiving conventional gemcitabine plus S-1 (GS), and patients receiving gemcitabine plus nab-paclitaxel (GnP) was determined by hybrid cell counting. 18F-Fluorodeoxyglucose positron-emission tomography (FDG-PET) scans and carbohydrate antigen 19-9 (CA19-9) concentrations were used to assess tumor activity before and after chemotherapy in the GnP group. Results: In this retrospective study of 65 patients, αSMA expression was reduced in the GnP group, as revealed by markedly disorganized collagen and a low density of αSMA-positive fibroblasts. There were significantly fewer αSMA-positive fibroblasts in the GnP than in the untreated and GS groups, but there was no significant difference between the latter two groups. αSMA density reflected a decrease in standardized uptake value on FDG-PET, but not CA19-9 concentration, after GnP chemotherapy. Conclusion: These data suggest that the GnP regimen induces stromal depletion, resulting in fewer CAFs.

12 June 2014 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
NINinomiya Itasu
Ninomiya Itasu
KOKouichi Okamoto
Kouichi Okamoto
KOKatsunobu Oyama
Katsunobu Oyama
HHHironori Hayashi
Hironori Hayashi
TMTomoharu Miyashita
Tomoharu Miyashita
TOTetsuo Ohta
Tetsuo Ohta

1 January 2020 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
HTHiroyuki Takamura
Hiroyuki Takamura
RGRyousuke Gabata
Ryousuke Gabata
YOYoshinao Obatake
Yoshinao Obatake
SNShinichi Nakanuma
Shinichi Nakanuma
HHHironori Hayashi
Hironori Hayashi
TOTetsuo Ohta
Tetsuo Ohta
Background and Objectives: Although cholangiolocellular carcinoma is considered a combined hepatocellular and cholangiocarcinoma, we feel that this classification is not appropriate. Therefore, we compared the diagnostic imaging findings, surgical prognosis, and pathological features of cholangiolocellular carcinoma with those of other combined hepatocellular and cholangiocarcinoma subtypes, hepatocellular carcinoma, and cholangiocarcinoma. Methods: The study patients included 7 with classical type combined hepatocellular and cholangiocarcinoma; 8 with stem cell feature, intermediate type combined hepatocellular and cholangiocarcinoma; 13 with cholangiolocellular carcinoma; 58 with cholangiocarcinoma; and 359 with hepatocellular carcinoma. All patients underwent hepatectomy or living-related donor liver transplantation from 2001 to 2014. Results: cholangiolocellular carcinoma could be distinguished from hepatocellular carcinom, other combined hepatocellular and cholangiocarcinoma subtypes, and cholangiocarcinoma by the presence of intratumoral Glisson’s pedicle, hepatic vein penetration, and tumor-staining pattern on angiography-assisted CT. Cholangiolocellular carcinoma was associated with a significantly lower SUV-max than that of cholangiocarcinoma on FDG-PET. Hepatocellular carcinoma, classical type, and cholangiolocellular carcinoma had significantly better prognoses than stem cell feature, intermediate type and cholangiocarcinoma. A cholangiocarcinoma component was detected in cholangiolocellular carcinoma that progressed to the hepatic hilum, and the cholangiocarcinoma component was found in perineural invasion and lymph node metastases. Conclusions: From the viewpoint of surgeon, cholangiolocellular carcinoma should be classified as a good-prognosis subtype of biliary tract carcinoma because of its tendency to differentiate into cholangiocarcinoma during its progression, and its distinctive imaging and few recurrence rates different from other combined hepatocellular and cholangiocarcinoma subtypes.

31 May 2019 in Intractable & Rare Diseases Research
Verified
Journal Article
Open access
PDF file
YFYuka Fujimoto
Yuka Fujimoto
YOYuki Ohya
Yuki Ohya
TITomoaki Irie
Tomoaki Irie
SKSayahito Kumamoto
Sayahito Kumamoto
ATAkira Tuji
Akira Tuji
YIYukihiro Inomata
Yukihiro Inomata
Hypogenesis or agenesis of right hepatic lobe is a rare abnormality and is generally associated with gallbladder and biliary tract abnormalities. Cases of biliary injury following cholecystectomy have been reported in patients with agenesis of right hepatic lobe because the anatomical anomalies complicate the surgical approach. We report a case of laparoscopic cholecystectomy in a patient with hypogenesis of right hepatic lobe. A 92-year-old male patient was admitted to our hospital with fever and right lower abdominal pain with suspected acute appendicitis. Abdominal computed tomography revealed gallstones with acute cholecystitis and hypogenesis of right hepatic lobe. He underwent laparoscopic cholecystectomy with the left semilateral decubitus position. The patient's postoperative course was uneventful. In conclusions, some patients with liver lobe hypoplasia do not present with the typical symptoms of acute cholecystitis due to dislocation of the gallbladder. The left semilateral decubitus position with modified placement of port sites is useful for laparoscopic cholecystectomy in patients with hypogenesis of right hepatic lobe.

12 September 2013 in Case Reports in Surgery
Verified
Journal Article
Open access
PDF file
HHHironori Hayashi
Hironori Hayashi
HTHiroyuki Takamura
Hiroyuki Takamura
YOYoshinao Ohbatake
Yoshinao Ohbatake
MSMasatoshi Shoji
Masatoshi Shoji
SNShin-Ichi Nakanuma
Shin-Ichi Nakanuma
TOTetsuo Ohta
Tetsuo Ohta
Biliary complications have great importance for liver transplant recipients because of affecting long-term prognosis. In rare situations, an internal hernia of the Roux-en-Y loop cause graft injury. A 42-year-old woman with a history of living donor liver transplantation 6 years ago presented with prolonged graft injury during the past 6 months. She suddenly developed ileus of the small bowel with internal hernia through the defect of the mesentery around the Roux-en-Y limb of the hepaticojejunostomy. Emergent surgery was performed to reduce the hernia and volvulus; also the mesenteric rent was closed with interrupted suture of silk. Internal hernia of the small bowel after liver transplantation is rare but causes graft injury due to associated biliary complications and rapid deterioration of patient’s condition.